Acetyl-L-Carnitine (ALCAR) — Supplements
Acetylated carnitine that crosses the blood-brain barrier; supports mitochondrial function, acetylcholine synthesis, and reverses age-related cognitive decline in multiple RCTs.
Overview
Acetyl-L-Carnitine (ALCAR) is the acetylated ester of L-Carnitine, structurally distinct in its ability to readily cross the blood-brain barrier — a property standard L-Carnitine lacks. This CNS penetration makes ALCAR a fundamentally different compound with a distinct indication profile: while standard L-Carnitine supports peripheral fatty acid transport into mitochondria, ALCAR delivers acetyl groups to the brain for acetylcholine synthesis, directly fueling cholinergic neurotransmission. A foundational pair of randomized controlled trials (Di Marzio et al.; Ames et al., 2003, Proceedings of the National Academy of Sciences) established that ALCAR supplementation reverses age-related mitochondrial dysfunction and oxidative damage in aged rats — with the effect amplified by combination with alpha-lipoic acid (creating the ALCAR + ALA longevity stack). In human clinical trials, ALCAR (1,500–3,000 mg/day) improved memory, cognitive speed, and attention in mild cognitive impairment and early Alzheimer's disease across multiple double-blind RCTs. A 2003 Cochrane meta-analysis of 21 trials (n=1,204) confirmed significant benefit for mild cognitive impairment over 3 months. ALCAR is also used in neuropathic pain (diabetic neuropathy), fatigue syndromes, and male infertility — with RCT evidence in each domain.
Indications
- Age-related cognitive decline and mild cognitive impairment
- Neuroprotection and cholinergic support
- Fatigue — including chronic fatigue syndrome and cancer treatment fatigue
- Neuropathic pain (diabetic peripheral neuropathy, HIV-associated neuropathy)
- Male infertility and sperm quality
- Depression (adjunctive — ALCAR as acetylcholine precursor affects mood circuits)
Mechanism of Action
ALCAR donates its acetyl group to choline in brain neurons, forming acetylcholine — the primary neurotransmitter of learning and memory circuits. Age-related decline in CNS acetylcholine contributes to cognitive dysfunction; ALCAR's blood-brain barrier penetrance makes it an effective oral acetylcholine precursor
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Acetyl-L-Carnitine (ALCAR) | 500–1,000 mg | Twice to three times daily (with food) | Common clinical dose: 1,500–3,000 mg/day total; start at 500 mg twice daily and titrate; cognitive benefit doses are higher than mitochondrial support doses |
Safety & Contraindications
- Generally well tolerated; most common side effects are GI (nausea, vomiting, diarrhea) — take with food
- Fishy body odor possible (TMA production from carnitine metabolism by gut bacteria) — less common than with plain L-carnitine but can occur
- May increase seizure risk in patients with a history of seizures — use with caution
- TMAO (trimethylamine N-oxide) production concern: gut bacteria convert carnitine to TMA → TMAO, which is associated with cardiovascular risk in observational studies; clinical significance of supplemental ALCAR doses on TMAO is debated
- Drug interaction: may enhance anticoagulant effect of warfarin — monitor INR
- Do not confuse with standard L-Carnitine — they are different compounds with different indications and CNS pharmacokinetics